Ignite Creation Date:
2024-07-17 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06478472
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-06-23
Brief Title:
Prospective Clinical Study of Orelabrutinib in Combination With Rituximab OR for Primary Marginal Zone Lymphoma MZL That Failed or Not Suitable for Local Therapy
Sponsor:
Organization:
The First Affiliated Hospital of Xiamen University
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
36
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| NA |
Observational Models:
Time Perspective List:
Who Masked List: